PINK1 and Parkinson disease: In 2020, Key J. et al. [91] demonstrated that ferritin superfamily and nucleotide surveillance regulation are strictly modulated by PINK1 in mouse and patient cells, exploring the possibility to employ iron chelator drugs in this subgroup of PD patients.